MedPath

LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Commercialized
Register Number

88047

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Aug 25, 2022

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number88047
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

LAPATINIBActive
Quantity: 250 mg
Name: LAPATINIB

ATC CLASSIFICATION (3)

L01E
L01EH
L01EH01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.